Roles of m6A mRNA Methylation in Innate Immunity
Roles of m6A mRNA Methylation in Innate Immunity
批准号:
10268233
负责人:
Yan Chun LI
金额:
$40.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-22 至 2025-08-31
关键词:
AcuteAdenosineBacterial InfectionsBindingBiological ProcessBiologyCause of DeathClinicalDataDevelopmentFeedbackGenetic TranscriptionGenetic TranslationGoalsGram-Negative Bacterial InfectionsHypersensitivityImmune responseImpairmentIn VitroInfectionInflammatoryIntensive Care UnitsLearningLipopolysaccharidesMacrophage ActivationMediatingMemoryMessenger RNAMetabolismMethylationMethyltransferaseModelingModificationMolecularMusMutant Strains MiceMyeloid CellsNF-kappa BNatural ImmunityOrganPathway interactionsPatientsPersonal SatisfactionPhysiologyPlayProductionProteinsReaderRegulationResolutionRoleSepsisSerumSiteStressSuppressor of Cytokine Signaling Family ProteinTissuesTranscriptTranslationsbiological adaptation to stresscecal ligation puncturechemokinecytokinecytokine release syndromegenetic informationin vitro Modelin vivomRNA StabilitymRNA Transcript Degradationmacrophagemethyl groupmortalityresponseseptic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Post-transcriptional modifications of mRNA have emerged as a central regulatory mechanism in genetic
information flow. N6-methyladenosine (m6A) is the most abundant post-transcriptional modification in
eukaryotic mRNAs. m6A mRNA methylation is reversible and dynamically regulated by writers, erasers and
readers. Writers are methyltransferases that install the methyl group on adenosine residues, erasers are
demethylases that remove the methyl group, and readers are proteins that recognize and interact with the m6A
site. m6A methylation influences all fundamental aspects of mRNA metabolism, including mRNA processing,
stability and translation. Despite tremendous progresses, the in vivo roles of m6A mRNA methylation in
macrophage biology remains unclear. Sepsis is a major clinical problem and leading cause of death in patients
in intensive care units. Sepsis is usually caused by Gram-negative bacterial infection that triggers a fast
cytokine storm. Macrophages as the first line of defense are the predominant producer of pro-inflammatory
cytokines during infection. Proper resolution of the cytokine response is essential for the host's well-being. The
intensity and duration of cytokine storm is delicately regulated by negative feedback regulatory loops, and the
SOCS family of proteins are the central players of this feedback regulatory mechanism. We have sought to
understand the role of m6A methylation in macrophage biology by genetically targeting METTL14, a core
subunit of the m6A methyltransferase (a writer). We found that mice carrying METTL14 deletion in myeloid
cells are hypersensitive in both cecal ligation puncture (CLP)- and lipopolysaccharide (LPS)-induced sepsis
models. These tissue-specific METTL14-mutant mice produced and maintained much higher levels of serum
pro-inflammatory cytokines and suffered much higher mortality than control mice. METTL14-depleted
macrophages produced and sustained much higher levels of pro-inflammatory cytokines than the control
macrophages, and the underlying cause is that METTL14 deletion impairs SOCS1 induction in macrophages
following bacterial infection or LPS challenge. Our data support the hypothesis that m6A methylation plays a
critical role in controlling the intensity and resolution of cytokine storm in sepsis by increasing Socs1 mRNA
stability and translation. Our data strongly suggest that LPS or bacterial infection activates the NF-κB pathway
that stimulates Socs1 mRNA transcription; LPS/bacterial infection further increases Socs1 m6A methylation by
promoting FTO (an eraser) mRNA degradation, and then YTHDF1 (a reader) binds to the Socs1 m6A sites to
promote Socs1 mRNA stability and increase its translation. In this proposal we will validate that SOCS1 is an
essential METTL14 target to control macrophage activation in septic response using in vivo and in vitro models
(Aim 1), validate that YTHDF1 is a critical reader to promote Socs1 mRNA stability and translation in septic
response (Aim 2), and validate that FTO is a critical eraser whose mRNA degradation promotes Socs1 m6A
methylation and greatly contributes to negative feedback control of macrophage activation (Aim 3).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Roles of m6A mRNA Methylation in Innate Immunity
-
批准号:10676807
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2020
-
负责人:Yan Chun LI
-
依托单位:
Roles of m6A mRNA Methylation in Innate Immunity
-
批准号:10462625
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2020
-
负责人:Yan Chun LI
-
依托单位:
(PQA1) Mechanism of Vitamin D Chemoprevention Against Colon Cancer
-
批准号:8590842
-
项目类别:
-
资助金额:$43.57万
-
财政年份:2013
-
负责人:Yan Chun LI
-
依托单位:
(PQA1) Mechanism of Vitamin D Chemoprevention Against Colon Cancer
-
批准号:8724458
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2013
-
负责人:Yan Chun LI
-
依托单位:
(PQA1) Mechanism of Vitamin D Chemoprevention Against Colon Cancer
-
批准号:8912882
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2013
-
负责人:Yan Chun LI
-
依托单位:
(PQA1) Mechanism of Vitamin D Chemoprevention Against Colon Cancer
-
批准号:9142043
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2013
-
负责人:Yan Chun LI
-
依托单位:
New drug VS-110 for treating inflammatory bowel diseases
-
批准号:8586283
-
项目类别:
-
资助金额:$29.92万
-
财政年份:2013
-
负责人:Yan Chun LI
-
依托单位:
Novel drug VS-105 for treatment of diabetic nephropathy
-
批准号:8313361
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2012
-
负责人:Yan Chun LI
-
依托单位:
Cardiovascular Effect of the Vitamin D Endocrine System.
-
批准号:7790591
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2007
-
负责人:Yan Chun LI
-
依托单位:
Cardiovascular Effect of the Vitamin D Endocrine System.
-
批准号:7393847
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2007
-
负责人:Yan Chun LI
-
依托单位:
Cardiovascular Effect of the Vitamin D Endocrine System.
-
批准号:7578834
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2007
-
负责人:Yan Chun LI
-
依托单位:
Cardiovascular Effect of the Vitamin D Endocrine System.
-
批准号:7264222
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2007
-
负责人:Yan Chun LI
-
依托单位:
Vitamin D and Diabetic Nephropathy
-
批准号:7229835
-
项目类别:
-
资助金额:$22.36万
-
财政年份:2006
-
负责人:Yan Chun LI
-
依托单位:
Vitamin D and Diabetic Nephropathy
-
批准号:7015174
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2006
-
负责人:Yan Chun LI
-
依托单位:
Preventive Role of VDR in Colorectal Carcinogenesis
-
批准号:7100940
-
项目类别:
-
资助金额:$7.49万
-
财政年份:2005
-
负责人:Yan Chun LI
-
依托单位:
Preventive Role of VDR in Colorectal Carcinogenesis
-
批准号:7003414
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2005
-
负责人:Yan Chun LI
-
依托单位:
Vitamin D: A Negative Regulator of Renin Expression
-
批准号:6603214
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2002
-
负责人:Yan Chun LI
-
依托单位:
Regulation of minerals and fluids excretion in vitamin D
-
批准号:6926960
-
项目类别:
-
资助金额:$12.46万
-
财政年份:2001
-
负责人:Yan Chun LI
-
依托单位:
Regulation of minerals and fluids excretion in vitamin D
-
批准号:6318956
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2001
-
负责人:Yan Chun LI
-
依托单位:
Regulation of minerals and fluids excretion in vitamin D
-
批准号:6768623
-
项目类别:
-
资助金额:$12.46万
-
财政年份:2001
-
负责人:Yan Chun LI
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: